Jin Xing Qi
Président chez HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD
Fortune : 1 654 M $ au 30/04/2024
Postes actifs de Jin Xing Qi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Président | 01/01/2003 | - |
| Zhejiang Management Research | Corporate Officer/Principal | 24/02/2010 | - |
| Hangzhou Pute Equity Investment Co. Ltd. | Président | 07/04/2011 | - |
Hangzhou Binjiang Investment Holding Co., Ltd.
 Hangzhou Binjiang Investment Holding Co., Ltd. MiscellaneousMiscellaneous Hangzhou Binjiang Investment Holding Co., Ltd. is an investment holding company based in Hangzhou, China. | Directeur/Membre du Conseil | - | - |
Hangzhou Xincheng Time Square Real Estate Co., Ltd.
 Hangzhou Xincheng Time Square Real Estate Co., Ltd. Real Estate DevelopmentFinance Part of Hangzhou Binjiang Real Estate Group Co., Ltd., Hangzhou Xincheng Time Square Real Estate Co., Ltd. develops and manages real estate property. The company is based in Hangzhou, China. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Jin Xing Qi
Anciens postes connus de Jin Xing Qi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Directeur/Membre du Conseil | 08/04/2011 | - |
| Fondateur | 08/04/2011 | - |
Formation de Jin Xing Qi
| Zhejiang University | Masters Business Admin |
Statistiques
Internationale
| Chine | 8 |
Opérationnelle
| Director/Board Member | 3 |
| Chairman | 2 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Finance | 4 |
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Finance |
| Entreprise privées | 5 |
|---|---|
| Zhejiang Management Research | |
| Hangzhou Pute Equity Investment Co. Ltd. | Finance |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
Hangzhou Binjiang Investment Holding Co., Ltd.
Hangzhou Binjiang Investment Holding Co., Ltd. MiscellaneousMiscellaneous Hangzhou Binjiang Investment Holding Co., Ltd. is an investment holding company based in Hangzhou, China. | Miscellaneous |
Hangzhou Xincheng Time Square Real Estate Co., Ltd.
Hangzhou Xincheng Time Square Real Estate Co., Ltd. Real Estate DevelopmentFinance Part of Hangzhou Binjiang Real Estate Group Co., Ltd., Hangzhou Xincheng Time Square Real Estate Co., Ltd. develops and manages real estate property. The company is based in Hangzhou, China. | Finance |
- Bourse
- Insiders
- Jin Xing Qi
- Expérience